Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy.
CONCLUSIONS: Restoration of the wild type and shorter form of dystrophin highlights the therapeutic potential of CRISPR technology for DMD.
PMID: 29173172 [PubMed - as supplied by publisher]
Source: Current Gene Therapy - Category: Genetics & Stem Cells Authors: Wong TWY, Cohn RD Tags: Curr Gene Ther Source Type: research
More News: Adenoviruses | Brain | Gene Therapy | Genetics | Muscular Dystrophy | Neurology | Reflex Sympathetic Dystrophy